CompaniesOtherUpdated Oct 14, 2026
Giraffe Bio
Private. Giraffe Bio develops biochemical reagents that improve mineral selectivity and recovery, designed for existing flotation circuits.
- Last round
- $6.4M Seed
- Backed by
- Orion Industrial Ventures
- Launched
- Not recorded
- People
- 1
Overview
Updated Oct 14, 2026
Every fact carries a numbered source. Where we can't source something, it says so.
- Stage
- Seed · as of 2026-10-131
- Sector
- Not recorded
- Geography
- Not recorded
- Founded
- Not recorded
Funding
How much has Giraffe Bio raised?
Rounds and backers, each sourced.
Opportunities For accredited investors
Ways to invest in this company through an Alphaneo vehicle, when one exists. This section looks the same on every company page until you have an accredited profile.
Opportunities, terms and data rooms are shown to accredited investors. Creating a profile takes two minutes, and you’re notified first when anything opens.
No live opportunities right now. Accredited investors are notified first when one opens.
Create an accredited profileA vehicle is never smaller than $1,000,000.
People
Who founded and leads Giraffe Bio?
Names and titles only, each sourced.
- Alejandro Buffo Sempéco-founder and CEO1
Sources
Every claim on this page traces to one of these. The numbers match the citations above.
- 1Giraffe Bio aims its bespoke biomolecules at the looming copper shortage opens in a new tabStage, Funding, People · accessed Oct 14, 2026
- 2Giraffe Bio — Next-generation reagents for copper flotation. opens in a new tabWebsite · accessed Oct 14, 2026